Protagonist Therapeutics, Inc (PTGX) · Fund holders
Which of the 64 well-known fund managers followed here own Protagonist Therapeutics, from the 13F each files after a quarter's end, and what each did in its latest quarter.
Held by
4
of 64 funds
Their stake
$6.23M
together
Bought
2
0 new, 2 added
Sold
2
0 sold out
The funds
| Fund | Share of its portfolio | Shares | Value | Latest quarter |
|---|---|---|---|---|
| Polen Capital Management2026-06-30 | 0.02% | 22,651 | $2.78M | Reduced 7% |
| Gotham Asset Management (Joel Greenblatt)2026-06-30 | 0.01% | 18,663 | $2.29M | Reduced 12% |
| Bridgewater Associates2026-06-30 | 0.00% | 9,269 | $1.14M | Added 76% |
| Duquesne Family Office (Stanley Druckenmiller)2026-06-30 | 0.59% | 208,900 | $25,607 | Added 31% |
A 13F shows a quarter's end and is filed up to 45 days later, so this is not what the funds hold today. All funds ›